Since abnormal splicing regulation has been closely linked to tumor cell proliferation and invasiveness [21], one might argue that DDX42 downregulation could endow RAS-mut NIFTPs with enhanced proliferative capacities and a tendency for more rapid growth. Here, DDX42 is linked to neoplasm.